Frontlight ResearchEarly access
Trial site
Reveal Research Institute
- 4running trials
- 1closed trial
The trials here
What the 5 trials at this site are about, from their registry records.
- Conditions
- Chronic spontaneous urticaria2 trials
- Atopic dermatitis (eczema)1 trial
- Melanoma1 trial
- Psoriasis1 trial
- Phase
- Phase 33 trials
- Phase 22 trials
- Status
- Active, not recruiting3 trials
- Completed1 trial
- Recruiting1 trial
- Lead sponsor
- Blueprint Medicines Corporation1 trial
- Hoffmann-La Roche1 trial
- Novartis Pharmaceuticals1 trial
- Regeneron Pharmaceuticals1 trial
- Takeda1 trial
Running trials
Active, not recruiting
Active, not recruiting
Study of BLU-808 in Chronic Inducible Urticaria (CIndU) and Chronic Spontaneous Urticaria (CSU)
Active, not recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Melanoma1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 15 Nov 2026